These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16173976)

  • 41. Topical tacrolimus in the treatment of localized scleroderma.
    Mancuso G; Berdondini RM
    Eur J Dermatol; 2003; 13(6):590-2. PubMed ID: 14721783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Desoximetasone 0.25% and tacrolimus 0.1% ointments versus tacrolimus alone in the treatment of atopic dermatitis.
    Hebert AA; Koo J; Fowler J; Berman B; Rosenberg C; Levitt J
    Cutis; 2006 Nov; 78(5):357-63. PubMed ID: 17186796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo.
    Xu AE; Zhang DM; Wei XD; Huang B; Lu LJ
    Int J Dermatol; 2009 Jan; 48(1):86-90. PubMed ID: 19126059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study.
    Duque MI; Yosipovitch G; Fleischer AB; Willard J; Freedman BI
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):519-21. PubMed ID: 15761435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study.
    Virtanen HM; Reitamo S; Kari M; Kari O
    Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of refractory atopic blepharoconjunctivitis with topical tacrolimus 0.03% dermatologic ointment.
    Sakarya Y; Sakarya R
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):94-6. PubMed ID: 22103968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus.
    Hodgson TA; Sahni N; Kaliakatsou F; Buchanan JA; Porter SR
    Eur J Dermatol; 2003; 13(5):466-70. PubMed ID: 14693491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
    Naylor M; Elmets C; Jaracz E; Rico JM
    J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tacrolimus ointment: utilization patterns in children under age 2 years.
    Housman TS; Norton AB; Feldman SR; Fleischer AB; Simpson EL; Hanifin JM; Antaya RJ
    Dermatol Online J; 2004 Jul; 10(1):2. PubMed ID: 15347484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical treatment of perianal eczema with tacrolimus 0.1%.
    Schauber J; Weisenseel P; Ruzicka T
    Br J Dermatol; 2009 Dec; 161(6):1384-6. PubMed ID: 19575757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical tacrolimus in alopecia areata.
    Price VH; Willey A; Chen BK
    J Am Acad Dermatol; 2005 Jan; 52(1):138-9. PubMed ID: 15627095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report.
    Goldman D
    J Am Acad Dermatol; 2001 Jun; 44(6):995-8. PubMed ID: 11369912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical tacrolimus: an effective therapy for facial psoriasis.
    Yamamoto T; Nishioka K
    Eur J Dermatol; 2003; 13(5):471-3. PubMed ID: 14693492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle.
    Breneman D; Fleischer AB; Abramovits W; Zeichner J; Gold MH; Kirsner RS; Shull TF; Crowe AW; Jaracz E; Hanifin JM;
    J Am Acad Dermatol; 2008 Jun; 58(6):990-9. PubMed ID: 18359127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
    Liao YH; Chiu HC; Tseng YS; Tsai TF
    Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of superior limbic keratoconjunctivitis with topical tacrolimus 0.03% ointment.
    Kymionis GD; Klados NE; Kontadakis GA; Mikropoulos DG
    Cornea; 2013 Nov; 32(11):1499-501. PubMed ID: 23770977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty.
    Dhaliwal JS; Mason BF; Kaufman SC
    Cornea; 2008 May; 27(4):488-93. PubMed ID: 18434855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.
    Elad S; Or R; Resnick I; Shapira MY
    Transpl Int; 2003 Sep; 16(9):665-70. PubMed ID: 12768230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Tacrolimus--a new therapeutic option for Hailey-Hailey-disease?].
    Reuter J; Termeer C; Bruckner-Tuderman L
    J Dtsch Dermatol Ges; 2005 Apr; 3(4):278-9. PubMed ID: 16370477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.